# Intravenous phage therapy for difficult-to-treat infections: a systematic review and meta-analysis of individual patient data

Source: [nature.com](https://www.nature.com/articles/s41467-026-79491-9) · 2026-11-20 · Life
Page: https://themorning.science/story/intravenous-phage-therapy-for-difficult-to-treat-infections-a-systematic-review-f9f5615fba28da92
Kind: research · Impact: medium

## In brief

- A systematic review and meta-analysis pools individual patient data on intravenous phage therapy for difficult-to-treat infections.
- It synthesises clinical, microbiological and safety outcomes.
- It also covers pharmacokinetic and immune neutralisation data.

## Why it matters

It consolidates patient-level evidence on intravenous phage therapy, which clinicians and researchers can use to judge its clinical, microbiological and safety profile for hard-to-treat infections.

## Timeline

- 2026-11-20: Published online in Nature Communications

## Coverage

- [Intravenous phage therapy for difficult-to-treat infections: a systematic review and meta-analysis of individual patient data](https://www.nature.com/articles/s41467-026-79491-9) — nature.com, 2026-11-20

Tags: phage therapy, meta-analysis, infectious disease, pharmacokinetics, immune neutralisation

---

Brief generated by AI (claude-haiku-5-5) from the reporting listed under Coverage. Headlines belong to their publishers. The Morning Science – https://themorning.science
